CompletedPhase 3NCT00884741
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Studying Gliosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Mark GilbertNRG Oncology
- Intervention
- 3-Dimensional Conformal Radiation Therapy(radiation)
- Enrollment
- 637 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2013
Study locations (30)
- Providence Hospital, Mobile, Alabama, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
- Arizona Oncology Services Foundation, Scottsdale, Arizona, United States
- Arizona Oncology Associates-West Orange Grove, Tucson, Arizona, United States
- Sutter Cancer Centers Radiation Oncology Services-Auburn, Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park, Cameron Park, California, United States
- Mercy San Juan Medical Center, Carmichael, California, United States
- John Muir Medical Center-Concord Campus, Concord, California, United States
- City of Hope Comprehensive Cancer Center, Duarte, California, United States
- California Cancer Center - North Fresno, Fresno, California, United States
- Cancer Care Associates of Fresno Medical Group Inc, Fresno, California, United States
- Saint Jude Medical Center, Fullerton, California, United States
- UC San Diego Moores Cancer Center, La Jolla, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Radiation Therapy Oncology Group · NRG Oncology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00884741 on ClinicalTrials.govOther trials for Gliosarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07134842A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.University College, London
- ENROLLING BY INVITATIONPHASE1NCT06896110Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade GliomaAndrew P. Groves
- RECRUITINGPHASE1NCT06934889Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaMemorial Sloan Kettering Cancer Center
- RECRUITINGNCT05756985Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain TissueBaptist Health South Florida
- RECRUITINGPHASE2NCT05864534Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed GlioblastomaNorthwestern University
- RECRUITINGNCT06954636Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational StudySied Kebir
- RECRUITINGPHASE1NCT04991870Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBMM.D. Anderson Cancer Center
- RECRUITINGPHASE1NCT05363826Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®Photolitec LLC